ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1886

Myocardial Fibrosis Detected By Magnetic Resonance Imaging Is a Predictor of Heart Failure in Systemic Sclerosis (SSc) Patients

Tatiana Sofia Rodriguez-Reyna1, Martha Morelos-Guzmán2, Pamela Mercado Velazquez3, Pablo Henrandez-Reyes4, Karla Montero-Duarte5, Cynthia Martinez-Reyes6, Carlos Reyes-Utrera6 and Carlos Nunez Alvarez3, 1Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Radiology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 3Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico, Mexico, 4Department of Cardiology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 5Department of Imaging and Radiology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico, 6Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: fibrosis, Heart disease, Morbidity and mortality and systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Clinical Aspects and Therapeutics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: In previous studies we showed that prevalence of myocardial fibrosis in SSc patients is 45% and is associated to diffuse disease (dcSSc) and lower left ventricle ejection fraction (LVEF); microvascular damage was also very frequent (79%). Our aim was to identify baseline characteristics associated to the development of cardiovascular outcomes (heart failure, coronary artery disease, arrhythmias, vasculopathy, and death) in SSc patients with previously documented myocardial fibrosis and microvascular damage.

Patients and Methods: We included 62 SSc patients who participated in the study of prevalence of myocardial fibrosis (2008-2010) and in our local SSc cohort. We performed baseline clinical evaluation, cardiac MRI, coronary angiotomography, transthoracic echocardiogram, and yearly clinical and cardiovascular evaluation that included Medsger’s severity scale items, electrocardiogram, echocardiogram, chest X ray or HRCT and spirometry; we registered presence and severity of internal organ involvement and cardiovascular outcomes. Ordinal variables were analyzed using Chi square test and Fisher test when appropriate, numeric variables were compared using Student’s t test or Mann Whitney U when appropriate, logistic regression was used to perform multivariable analysis.

Results: We obtained follow-up information from 61 patients (29 dcSSc, 32 lcSSc), mean follow up was 43.5 months. Univariate analysis showed that elevated basal ultrasensitive CRP was associated to higher overall mortality at the end of follow-up (p=0.003, OR=22, 95% CI 2.3-209), and microvascular damage at baseline was associated to recurrent digital tip ischemic ulcers (p=0.05). Multivariable analysis showed that: myocardial fibrosis, particularly in the middle LV segments was associated to the development of heart failure (p=0.04, OR 8.9, 95%CI 1.07-76); lower LVEF was associated to the development of coronary artery disease (p=0.02, OR 0.66, 95%CI 0.47-0.9); finally, insertion point fibrosis (p=0.01, OR 11.1, 95%CI 2.5-55.5) and elevated ultrasensitive CRP (p=0.04, OR 5.2, 95%CI 1.82-25.6) were associated to recurrent digital tip ulcers.

Conclusion: This study shows that elevated ultrasensitive CRP, the presence of myocardial fibrosis and microvascular damage are predictors of cardiovascular outcomes in SSc patients. Patients with myocardial fibrosis experience progressive decline in LVEF when compared to those without fibrosis. Future studies should focus on therapeutic strategies for this group of patients.


Disclosure: T. S. Rodriguez-Reyna, None; M. Morelos-Guzmán, None; P. Mercado Velazquez, None; P. Henrandez-Reyes, None; K. Montero-Duarte, None; C. Martinez-Reyes, None; C. Reyes-Utrera, None; C. Nunez Alvarez, None.

To cite this abstract in AMA style:

Rodriguez-Reyna TS, Morelos-Guzmán M, Mercado Velazquez P, Henrandez-Reyes P, Montero-Duarte K, Martinez-Reyes C, Reyes-Utrera C, Nunez Alvarez C. Myocardial Fibrosis Detected By Magnetic Resonance Imaging Is a Predictor of Heart Failure in Systemic Sclerosis (SSc) Patients [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/myocardial-fibrosis-detected-by-magnetic-resonance-imaging-is-a-predictor-of-heart-failure-in-systemic-sclerosis-ssc-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/myocardial-fibrosis-detected-by-magnetic-resonance-imaging-is-a-predictor-of-heart-failure-in-systemic-sclerosis-ssc-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology